Dadvand, P, Gascon, M, Bustamante, M, Rivas, I, Foraster, M, Basagana, X, Cosin, M, Eixarch, E, Ferrer, M, Gratacos, E, Herrera, LG, Jimenez-Arenas, P, Júlvez, J, Morillas, A, Nieuwenhuijsen, MJ, Persavento, C, Pujol, J, Querol, X, García, OS, Vrijheid, M, Llurba, E, Gomez-Roig, MD, Sunyer, J. Cohort Profile: Barcelona Life Study Cohort (BiSC). INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2024; 53(3)DOI:10.1093/ije/dyae063. PMID:38725298. IF:5.900(Q1/1D).

Gonzalez, R, Gonce, A, Gil, MD, Mazarico, E, Ferriols-Perez, E, Toro, P, Llurba, E, Saez, E, Rodriguez-Zambrano, MA, Garcia-Otero, L, Lopez, M, Santacruz, B, Roman, MA, Paya, A, Alonso, S, Cruz-Lemini, M, Pons-Duran, C, Herrera, LB, Chen, HLY, Bardaji, A, Quinto, L, Menendez, C. Efficacy and safety of hydroxychloroquine for treatment of mild SARS-CoV-2 infection and prevention of COVID-19 severity in pregnant and postpartum women: A randomized, double-blind, placebo-controlled trial. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024; 103(3)DOI:10.1111/aogs.14745. PMID:38098221. IF:3.100(Q1/2D).

Domínguez-Gallardo, C, Ginjaume-García, N, Ullmo, J, Parra, J, Vázquez, A, Cruz-Lemini, M, Llurba, E. Fetal Left Ventricle Function Evaluated by Two-Dimensional Speckle-Tracking Echocardiography across Clinical Stages of Severity in Growth-Restricted Fetuses. Diagnostics. 2024; 14(5)DOI:10.3390/diagnostics14050548. PMID:38473020. IF:3.300(Q1/2D).

Llurba, E, Crispi, F, Crovetto, F, Youssef, L, Delgado, JL, Puig, I, Mora, J, Krofta, L, Mackova, K, Martinez-Varea, A, Tubau, A, Ruiz, A, Paya, A, Prat, M, Chantraine, F, Comas, C, Kajdy, A, Lopez-Tinajero, MF, Figueras, F, Gratacos, E. Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study. BMJ Open. 2024; 14(3)DOI:10.1136/bmjopen-2023-076201. PMID:38458783. IF:2.300(Q2/3D).

Vega Puyal L., Llurba E., Ferrer Q., Dolader Codina P., Sánchez García O., Montoliu Ruiz A., Sanchez-de-Toledo J.. Neurodesarrollo a los 2 años en cardiopatía congénita: utilidad pronóstica de los marcadores de daño cerebral. ANALES DE PEDIATRIA. 2024; 100(1)DOI:10.1016/j.anpedi.2023.10.007. PMID:38185573. IF:2.100(Q2/4D).

Esteve-Valverde, E, Alijotas-Reig, J, Belizna, C, Marques-Soares, J, Anunciacion-Llunell, A, Feijoo-Masso, C, Saez-Comet, L, Mekinian, A, Ferrer-Oliveras, R, Lefkou, E, Morales-Perez, S, Hoxha, A, Tincani, A, Nalli, C, Pardos-Gea, J, Marozio, L, Maina, A, Espinosa, G, Cervera, R, De Carolis, S, Latino, O, Udry, S, Llurba, E, Garrido-Gimenez, C, Trespidi, L, Gerosa, M, Chighizola, CB, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Tabacco, S, Arnau, A, Miro-Mur, F. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group (vol 163, pg 29, 2023). PLACENTA. 2023; 138DOI:10.1016/j.placenta.2023.04.016. PMID:37146536. IF:3.000(Q1/3D).

Jia Y.-J., Ghi T., Pereira S., Gracia Perez-Bonfils A., Chandraharan E.. Pathophysiological interpretation of fetal heart rate tracings in clinical practice. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2023; 228(6)DOI:10.1016/j.ajog.2022.05.023. PMID:37270259. IF:8.700(Q1/1D).

Nan, MN, Garcia-Osuna, A, Mora, J, Trilla, C, Antonijuan, A, Orantes, V, Cruz-Lemini, M, Blanco-Vaca, F, Llurba, E. Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy. Biomedicines. 2023; 11(5)DOI:10.3390/biomedicines11051327. PMID:37238997. IF:3.900(Q1/3D).